Anti-PERK antibody
3
(2 Reviews)
|
(82 Publications)
Rabbit Polyclonal PERK antibody. Suitable for WB, ICC/IF and reacts with Human samples. Cited in 82 publications. Immunogen corresponding to Synthetic Peptide within Human EIF2AK3.
View Alternative Names
PEK, PERK, EIF2AK3, Eukaryotic translation initiation factor 2-alpha kinase 3, PRKR-like endoplasmic reticulum kinase, Pancreatic eIF2-alpha kinase, Protein tyrosine kinase EIF2AK3, HsPEK
- ICC/IF
Unknown
Immunocytochemistry/ Immunofluorescence - Anti-PERK antibody (AB65142)
Immunofluorescence analysis of HepG2 cells using ab65142 at a 1/500-1/1000 dilution. Left image untreated. Right image treated with immunising peptide.
- WB
Unknown
Western blot - Anti-PERK antibody (AB65142)
The amount of positive control loading for the WB is 5-30 ug of total protein.
The amount of the peptide for the WB is 5-10 ug.
All lanes:
Western blot - Anti-PERK antibody (ab65142) at 1/500 dilution
Lane 1:
Extracts from Hela cells
Lane 2:
Extracts from HepG2 cells
Lane 3:
Extracts from HepG2 cells, plus immunising peptide
Predicted band size: 125 kDa
Observed band size: 125 kDa
false
- WB
Lab
Western blot - Anti-PERK antibody (AB65142)
Western blot : Anti-EIF2AK3 antibody (ab65142) staining at 1/1000 dilution, shown in green; Mouse anti-CANX [CANX/1543] (ab238078) loading control staining at 1/20000 dilution, shown in magenta. In Western blot, ab65142 was shown to bind specifically to EIF2AK3. A band was observed at 145 kDa in wild-type A549 cell lysates with no signal observed at this size in EIF2AK3 knockout cell line. To generate this image, wild-type and EIF2AK3 knockout A549 cell lysates were analysed. First, samples were run on an SDS-PAGE gel then transferred onto a nitrocellulose membrane. Membranes were blocked in 3 % milk in TBS-0.1 % Tween® 20 (TBS-T) before incubation with primary antibodies overnight at 4 °C. Blots were washed four times in TBS-T, incubated with secondary antibodies for 1 h at room temperature, washed again four times then imaged. Secondary antibodies used were Goat anti-Rabbit IgG H&L 800CW and Goat anti-Mouse IgG H&L 680RD at 1/20000 dilution.
All lanes:
Western blot - Anti-PERK antibody (ab65142) at 1/1000 dilution
Lane 1:
Wild-type A549 cell lysate at 20 µg
Lane 2:
EIF2AK3 knockout A549 cell lysate at 20 µg
Lane 2:
Western blot - Human EIF2AK3 knockout A549 cell line (<a href='/en-us/products/cell-lines/human-eif2ak3-knockout-a549-cell-line-ab288905'>ab288905</a>)
Lane 3:
MCF7 cell lysate at 20 µg
Lane 4:
Human eye cell lysate at 20 µg
Secondary
All lanes:
Goat anti-Rabbit IgG H&L 800CW and Goat anti-Mouse IgG H&L 680RD at 1/20000 dilution
Observed band size: 145 kDa
false
Reactivity data
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
PERK plays an important role in maintaining cellular homeostasis during stress conditions. It forms part of a larger complex that regulates the adaptive response to ER stress. Upon activation PERK arrests general protein translation while allowing for selective translation of stress response proteins. This mechanism prevents the accumulation of unfolded proteins and assists in the survival of cells under adverse conditions. PERK also contributes to the regulation of oxidative stress and cell apoptosis adding further layers to its biological significance.
Pathways
PERK's activity intersects with the integrated stress response and UPR pathways. It shares a close functional relationship with proteins like ATF4 which is synthesized upon PERK activation and is important for the transcription of genes related to stress adaptation. The UPR pathway coordinates with the IRE1 and ATF6 pathways forming an important network for managing ER stress. These pathways collectively ensure cellular resilience adjusting metabolic demands and promoting cellular recovery.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (82)
Recent publications for all applications. Explore the full list and refine your search
JCI insight 10: PubMed40401526
2025
Applications
Unspecified application
Species
Unspecified reactive species
Brain and behavior 15:e70499 PubMed40329779
2025
Applications
Unspecified application
Species
Unspecified reactive species
Bone research 13:47 PubMed40229258
2025
Applications
Unspecified application
Species
Unspecified reactive species
In vivo (Athens, Greece) 38:2228-2238 PubMed39187325
2024
Applications
Unspecified application
Species
Unspecified reactive species
PloS one 19:e0302662 PubMed38748716
2024
Applications
Unspecified application
Species
Unspecified reactive species
Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics 21:e00335 PubMed38368172
2024
Applications
Unspecified application
Species
Unspecified reactive species
Aging 15:3759-3770 PubMed37166421
2023
Applications
Unspecified application
Species
Unspecified reactive species
Cell biology and toxicology 39:2665-2684 PubMed36746840
2023
Applications
Unspecified application
Species
Unspecified reactive species
Cancer medicine 12:8306-8318 PubMed36515089
2022
Applications
Unspecified application
Species
Unspecified reactive species
Disease markers 2022:9340353 PubMed36523813
2022
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com